Abstract:Introduction: Efficient delivery of therapeutics across the blood-brain barrier (BBB) for the treatment of central nervous system (CNS) tumors is a major challenge to the development of safe and efficacious therapies. Locoregional drug delivery platforms offer an improved therapeutic index by achieving high drug concentrations in the target tissue with negligible systemic exposure. Intrathecal (intraventricular) [IT] and convection-enhanced delivery [CED] are two clinically relevant methods being employed for various CNS malignancies. Both of these standalone platforms suffer from passive post-administration distribution forces, sometimes limiting the desired distribution for tumor therapy. Focused ultrasound and microbubble-mediated blood-brain barrier opening (FUS-BBBO) is a recent modality used for enhanced drug delivery. It is postulated that coupling of FUS with these alternative delivery routes may provide benefits. Multimodality FUS may provide the desired ability to increase the depth of parenchymal delivery following IT administration and provide a means for contour directionality with CED. Further, the transient enhanced permeability achieved with FUS-BBBO is well established, but drug residence and transit times, important to clinical dose scheduling, have not yet been defined. The present investigation comprises two discrete studies: 1. Conduct a comprehensive quantitative evaluation to elucidate the effect of FUS-BBBO as it relates to varying routes of administration (IT and IV) in its capacity to facilitate drug penetration within the striatal-thalamic region. 2. Investigate the impact of combining FUS-BBBO with CED on drug distribution, with a specific focus on the temporal dynamics of drug retention within the target region. Methods: Firstly, we quantitatively assessed how FUS-BBBO coupled with IT and IV altered fluorescent dye (Dextran 2000 kDa and 70 kDa) distribution and concentration in a predetermined striatal-thalamic region in naïve mice. Secondly, we analyzed the pharmacokinetic effects of using FUS mediated BBB disruption coupled with CED by measuring the volume of distribution and time-dependent concentration of the dye. Results: Our results indicate that IV administration coupled with FUS-BBBO successfully enhances delivery of dye into the pre-defined sonication targets. Conversely, measurable dye in the sonication target was consistently less after IT administration. FUS enhances the distribution volume of dye after CED. Furthermore, a shorter time of residence was observed when CED was coupled with FUS-BBBO application when compared to CED alone. Conclusion: 1. Based on our findings, IV delivery coupled with FUS-BBBO is a more efficient means for delivery to deep targets (i.e. striatal-thalamic region) within a predefined spatial conformation compared to IT administration. 2. FUS-BBBO increases the volume of distribution (Vd) of dye after CED administration, but results in a shorter time of residence. Whether this finding is reproducible with other classes of agents (e.g., cytotoxic agents, antibodies, viral particles, cellular therapies) needs to be studied.

Local fluorouracil chemotherapy interferes with neural and behavioral recovery after brain tumor-like mass compression.

Interruption of Functional Recovery by the NMDA Glutamate Antagonist MK801 after Compression of the Sensorimotor Cortex: Implications for Treatment of Tumors or Other Mass-Related Brain Injuries

The Problems of Monitoring Response to Chemotherapy in Subcutaneously Implanted 9L Glioma Using Apparent Diffusion Coefficient of Water and 23na Magnetic Resonance Imaging

Mass-related traumatic tissue displacement and behavior: a screen for treatments that reduce [corrected] harm to bystander cells and recovery of function.

Interaction of Chemotherapy and Radiotherapy in Altering the Morphology of Subcortical Structures in Patients With Nasopharyngeal Carcinoma

Interaction of Chemotherapy and Radiotherapy in Altering the Shape of Subcortical Structures in Patients with Nasopharyngeal Carcinoma.

Sensorimotor Deficits Associated with Brain Tumor Progression and Tumor-Induced Brain Plasticity Mechanisms.

Intratumoral Chemotherapy: The Effects of Drug Concentration and Dose Apportioning on Tumor Cell Injury

Predicting and Monitoring Response to Chemotherapy by 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea in Subcutaneously Implanted 9L Glioma Using the Apparent Diffusion Coefficient of Water and 23na MRI

Focused Delivery of Chemotherapy to Augment Surgical Management of Brain Tumors

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments

Influence of focused ultrasound on locoregional drug delivery to the brain: Potential implications for brain tumor therapy

Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen

Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model

Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis

Dose‐dependent cranial irradiation associations with brain structures and neuropsychological outcomes in children with posterior fossa brain tumors

Cnsc-04. Understanding Pediatric Brain Tumor Chemotherapy Induced Long-Term Deficits In High-Order Neurocognitive And Sensorimotor Function

Neuroimaging Advances in Chemotherapy-Related Cognitive Impairment: from Clinical to Preclinical Research

Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors

Changes in cognition and neuroinflammation in a rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically

Chemotherapy Potentially Facilitates The Occurrence Of Radiation Encephalopathy In Patients With Nasopharyngeal Carcinoma Following Radiotherapy: A Multiparametric Magnetic Resonance Imaging Study